Artículos de revistas sobre el tema "IGF-2 Binding Protein-2 (IGF2BP3)"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "IGF-2 Binding Protein-2 (IGF2BP3)".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Cao, Junguo, Qingchun Mu y Haiyan Huang. "The Roles of Insulin-Like Growth Factor 2 mRNA-Binding Protein 2 in Cancer and Cancer Stem Cells". Stem Cells International 2018 (2018): 1–15. http://dx.doi.org/10.1155/2018/4217259.
Texto completoPalanichamy, Jayanth Kumar, Tiffany Tran, Jorge Contreras, Thilini R. Fernando y Dinesh S. Rao. "Role Of Insulin Like Growth Factor mRNA Binding Protein-3 (IGF2BP3) In Mixed Lineage Leukemia (MLL) Positive B-Cell Lymphomas". Blood 122, n.º 21 (15 de noviembre de 2013): 3816. http://dx.doi.org/10.1182/blood.v122.21.3816.3816.
Texto completoYin, Huadong, Haorong He, Xiaoxu Shen, Jing Zhao, Xinao Cao, Shunshun Han, Can Cui et al. "miR-9-5p Inhibits Skeletal Muscle Satellite Cell Proliferation and Differentiation by Targeting IGF2BP3 through the IGF2-PI3K/Akt Signaling Pathway". International Journal of Molecular Sciences 21, n.º 5 (28 de febrero de 2020): 1655. http://dx.doi.org/10.3390/ijms21051655.
Texto completoWächter, Kristin, Marcel Köhn, Nadine Stöhr y Stefan Hüttelmaier. "Subcellular localization and RNP formation of IGF2BPs (IGF2 mRNA-binding proteins) is modulated by distinct RNA-binding domains". Biological Chemistry 394, n.º 8 (1 de agosto de 2013): 1077–90. http://dx.doi.org/10.1515/hsz-2013-0111.
Texto completoWang, Peng-Fei, Xiaoyu Wang, Min Liu, Zheng Zeng, Caiji Lin, Wenwen Xu, Wenqing Ma et al. "The Oncogenic Functions of Insulin-like Growth Factor 2 mRNA-Binding Protein 3 in Human Carcinomas". Current Pharmaceutical Design 26, n.º 32 (24 de septiembre de 2020): 3939–54. http://dx.doi.org/10.2174/1381612826666200413080936.
Texto completoPanebianco, Federica, Lindsey M. Kelly, Pengyuan Liu, Shan Zhong, Sanja Dacic, Xiaosong Wang, Aatur D. Singhi et al. "THADA fusion is a mechanism of IGF2BP3 activation and IGF1R signaling in thyroid cancer". Proceedings of the National Academy of Sciences 114, n.º 9 (13 de febrero de 2017): 2307–12. http://dx.doi.org/10.1073/pnas.1614265114.
Texto completoZhang, Haotian, Junjie Tang, Xiaowei Gong y Chenjun Huang. "Insulin-Like Growth Factor 2 mRNA Binding Protein 3 Suppresses Ferroptosis in Non-Small Cell Lung Cancer via Stabilizing m6A Modification of Fanconi Anemia Group D2 Protein". Journal of Biomedical Nanotechnology 19, n.º 8 (1 de agosto de 2023): 1390–99. http://dx.doi.org/10.1166/jbn.2023.3643.
Texto completode Vasconcellos, Jaira F., Colleen Byrnes, Y. Terry Lee, Pauline C. Xu, Antoinette Rabel y Jeffery L. Miller. "IGF2BP3 Moderately Increases Fetal Hemoglobin Levels in Human Adult Erythroblasts". Blood 128, n.º 22 (2 de diciembre de 2016): 2464. http://dx.doi.org/10.1182/blood.v128.22.2464.2464.
Texto completoZhang, Jing, Fanghui Ding, Dan Jiao, Qiaozhi Li y Hong Ma. "The Aberrant Expression of MicroRNA-125a-5p/IGF2BP3 Axis in Advanced Gastric Cancer and Its Clinical Relevance". Technology in Cancer Research & Treatment 19 (1 de enero de 2020): 153303382091733. http://dx.doi.org/10.1177/1533033820917332.
Texto completoLiu, Xin, Jiayu Chen, Wenliang Chen, Yangtao Xu, Yang Shen y Ximing Xu. "Targeting IGF2BP3 in Cancer". International Journal of Molecular Sciences 24, n.º 11 (29 de mayo de 2023): 9423. http://dx.doi.org/10.3390/ijms24119423.
Texto completoZhu, Lin, Xing Gao, Yun Du, Min Tang, Xiaofei Guo, Zhigang Chen, Yulong Liu y Yimin Lu. "Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 and Its Related Molecules as Potential Biomarkers in Small-Cell Lung Cancer". BioMed Research International 2022 (7 de julio de 2022): 1–14. http://dx.doi.org/10.1155/2022/5774339.
Texto completoWu, Tao, Xuan Zhang, Lu Xing, Dingguo Pan, Ping Liu, Rong Ding, Renfang Yang, Xudong Yang y Yunfeng Li. "Abnormal Expression of N6-Methyladenosine RNA Methylation Regulator IGF2BP3 in Colon Cancer Predicts a Poor Prognosis". Disease Markers 2022 (30 de mayo de 2022): 1–27. http://dx.doi.org/10.1155/2022/5883101.
Texto completoMäkinen, Artturi, Atte Nikkilä, Teppo Haapaniemi, Laura Oksa, Juha Mehtonen, Matti Vänskä, Merja Heinäniemi, Timo Paavonen y Olli Lohi. "IGF2BP3 Associates with Proliferative Phenotype and Prognostic Features in B-Cell Acute Lymphoblastic Leukemia". Cancers 13, n.º 7 (25 de marzo de 2021): 1505. http://dx.doi.org/10.3390/cancers13071505.
Texto completoWang, Sihyung, Youngmi Jung, Jeongeun Hyun, Matthew Friedersdorf, Seh-Hoon Oh, Jieun Kim, Richard T. Premont, Jack D. Keene y Anna Mae Diehl. "RNA Binding Proteins Control Transdifferentiation of Hepatic Stellate Cells into Myofibroblasts". Cellular Physiology and Biochemistry 48, n.º 3 (2018): 1215–29. http://dx.doi.org/10.1159/000491987.
Texto completoKlingbeil, Kyle D., Jack Pengfei Tang, Sarah M. Dry, Fritz C. Eilber, Dinesh S. Rao, Brian E. Kadera y Anusha Kalbasi. "Abstract 3490: IGF2BP3 (IMP3) expression is associated with worse survival in well-differentiated/dedifferentiated (WD/DD) liposarcoma". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 3490. http://dx.doi.org/10.1158/1538-7445.am2022-3490.
Texto completoSuvasini, Ramaswamy, Bhargava Shruti, Balaram Thota, Sridevi Vijay Shinde, Dinorah Friedmann-Morvinski, Zahid Nawaz, Krishnarao Venkatesh Prasanna et al. "Insulin Growth Factor-2 Binding Protein 3 (IGF2BP3) Is a Glioblastoma-specific Marker That Activates Phosphatidylinositol 3-Kinase/Mitogen-activated Protein Kinase (PI3K/MAPK) Pathways by Modulating IGF-2". Journal of Biological Chemistry 286, n.º 29 (25 de mayo de 2011): 25882–90. http://dx.doi.org/10.1074/jbc.m110.178012.
Texto completoHyun, Jeongeun, Seh-Hoon Oh, Richard T. Premont, Cynthia D. Guy, Carl L. Berg y Anna Mae Diehl. "Dysregulated activation of fetal liver programme in acute liver failure". Gut 68, n.º 6 (22 de enero de 2019): 1076–87. http://dx.doi.org/10.1136/gutjnl-2018-317603.
Texto completoHuang, Huilin, Hengyou Weng, Mingli Sun, Huizhe Wu, Zhenhua Chen, Savanna Stanford, Xiaolan Deng, Rui Su, Minjie Wei y Jianjun Chen. "The Oncogenic Role of N6-Methyladenosine Reader Protein IGF2BP3 in Acute Myeloid Leukemia". Blood 132, Supplement 1 (29 de noviembre de 2018): 1334. http://dx.doi.org/10.1182/blood-2018-99-117535.
Texto completoSkibiel, C., S. Ren y L. Reid. "Clinicopathologic features of thyroid neoplasm with THADA-IGF2BP3 fusion". American Journal of Clinical Pathology 156, Supplement_1 (1 de octubre de 2021): S53—S54. http://dx.doi.org/10.1093/ajcp/aqab191.109.
Texto completoZhao, Wei, Dan Lu y Jun Zhang. "Insulin growth factor-2 binding protein 3 (IGF2BP3) to promote lung tumorigenesis viaregulation of p53 stability." Journal of Clinical Oncology 34, n.º 15_suppl (20 de mayo de 2016): e23013-e23013. http://dx.doi.org/10.1200/jco.2016.34.15_suppl.e23013.
Texto completoFan, Jin, Mengqi Zhuang, Wei Fan y Ming Hou. "RNA N6-methyladenosine reader IGF2BP3 promotes acute myeloid leukemia progression by controlling stabilization of EPOR mRNA". PeerJ 11 (30 de agosto de 2023): e15706. http://dx.doi.org/10.7717/peerj.15706.
Texto completoHuang, Shan, Zheng Wu, Yunyun Cheng, Wenzhen Wei y Linlin Hao. "Insulin-like growth factor 2 mRNA binding protein 2 promotes aerobic glycolysis and cell proliferation in pancreatic ductal adenocarcinoma via stabilizing GLUT1 mRNA". Acta Biochimica et Biophysica Sinica 51, n.º 7 (15 de mayo de 2019): 743–52. http://dx.doi.org/10.1093/abbs/gmz048.
Texto completoZhao, Wei, Dan Lu, Liang Liu, Juan Cai, Yu Zhou, Ying Yang, Yu Zhang y Jun Zhang. "Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) promotes lung tumorigenesis via attenuating p53 stability". Oncotarget 8, n.º 55 (27 de septiembre de 2017): 93672–87. http://dx.doi.org/10.18632/oncotarget.21280.
Texto completoShen, Xiaoxu, Yuanhang Wei, Guishuang You, Wei Liu, Felix Kwame Amevor, Yao Zhang, Haorong He et al. "Circular PPP1R13B RNA Promotes Chicken Skeletal Muscle Satellite Cell Proliferation and Differentiation via Targeting miR-9-5p". Animals 11, n.º 8 (13 de agosto de 2021): 2396. http://dx.doi.org/10.3390/ani11082396.
Texto completoElagib, Kamaleldin E., Chih-Huan Lu, Goar Mosoyan, Ewelina Zasadzińska, Daniel R. Foltz, Peter Balogh, Els Verhoeyen et al. "An IGF2BP3-Cdk9 Pathway Governs the Human Fetal-Adult Megakaryocyte Transition". Blood 128, n.º 22 (2 de diciembre de 2016): 886. http://dx.doi.org/10.1182/blood.v128.22.886.886.
Texto completoLochhead, Paul, Yu Imamura, Teppei Morikawa, Aya Kuchiba, Mai Yamauchi, Xiaoyun Liao, Zhi Rong Qian et al. "Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer". European Journal of Cancer 48, n.º 18 (diciembre de 2012): 3405–13. http://dx.doi.org/10.1016/j.ejca.2012.06.021.
Texto completoElagib, Kamaleldin E., Chih-Huan Lu, Ewelina Zasadzińska, Daniel R. Foltz, Peter Balogh y Adam N. Goldfarb. "The Distinctive Morphogenesis of Infantile Megakaryopoiesis Is Associated with Altered P-TEFb Regulation By the Oncofetal Factor IGF2BP3". Blood 124, n.º 21 (6 de diciembre de 2014): 2911. http://dx.doi.org/10.1182/blood.v124.21.2911.2911.
Texto completoChristiansen, Jan, Astrid M. Kolte, Thomas v. O. Hansen y Finn C. Nielsen. "IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes". Journal of Molecular Endocrinology 43, n.º 5 (8 de mayo de 2009): 187–95. http://dx.doi.org/10.1677/jme-09-0016.
Texto completoTuo, Hu, Baozhen Yao, Bing He, Shiqian Yu, Danni Li, Wenjing Li y Lin Jin. "Silence of Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 Prevents Vascular Smooth Muscle Cells Proliferation via Nuclear Factor of Activated T Cells Isoform-3/Ca2+/Calmodulin Pathway". Journal of Biomaterials and Tissue Engineering 11, n.º 4 (1 de abril de 2021): 704–10. http://dx.doi.org/10.1166/jbt.2021.2747.
Texto completoBell, Jessica L., Raseswari Turlapati, Tao Liu, Johannes H. Schulte y Stefan Hüttelmaier. "IGF2BP1 Harbors Prognostic Significance by Gene Gain and Diverse Expression in Neuroblastoma". Journal of Clinical Oncology 33, n.º 11 (10 de abril de 2015): 1285–93. http://dx.doi.org/10.1200/jco.2014.55.9880.
Texto completoFalih, Zubaida, Bayadir Ali Wannas Khodair, Noaman Ibadi Mohammed y Tahseen Kadhem Mohammed. "Insulin-like Growth Factor-2 Binding Protein-2 Gene Polymorphisms in Iraqi Patients with Type 2 Diabetes Mellitus". Open Access Macedonian Journal of Medical Sciences 10, A (21 de mayo de 2022): 1178–83. http://dx.doi.org/10.3889/oamjms.2022.9754.
Texto completoHack, Theresa, Stefanie Bertram, Guntram Büsche, Helmut Hanenberg, Ludger Klein-Hitpass, Nils Von Neuhoff, Dirk Reinhardt, Markus Schneider y Mareike Rasche. "Induction of a Leukemic Bone Marrow Niche Mediated By TGFB1 of Leukemic Blasts in Pediatric Acute Mekaryoblastic Leukemia: Results of an in Vitro and In Vivo Analysis". Blood 134, Supplement_1 (13 de noviembre de 2019): 3734. http://dx.doi.org/10.1182/blood-2019-126536.
Texto completoMancarella, Caterina y Katia Scotlandi. "40 YEARS OF IGF1: IGF system in sarcomas: a crucial pathway with many unknowns to exploit for therapy". Journal of Molecular Endocrinology 61, n.º 1 (julio de 2018): T45—T60. http://dx.doi.org/10.1530/jme-17-0250.
Texto completoElagib, Kamaleldin E., Ashton Brock, Goar Mosoyan, Cara Clementelli, Lorrie L. Delehanty, Alexandra Pacheco-Benichou, Corinne Fruit et al. "Harnessing a Novel Dyrk1a-Ablim2-MKL1 Regulatory Module in Megakaryocyte Morphogenesis to Enable Scalable Platelet "Pharming"". Blood 134, Supplement_1 (13 de noviembre de 2019): 3250. http://dx.doi.org/10.1182/blood-2019-129049.
Texto completoTangprasittipap, Amornrat, Pavita Kaewprommal, Orapan Sripichai, Nuankanya Sathirapongsasuti, Chonthicha Satirapod, Philip J. Shaw, Jittima Piriyapongsa y Suradej Hongeng. "Comparison of gene expression profiles between human erythroid cells derived from fetal liver and adult peripheral blood". PeerJ 6 (31 de agosto de 2018): e5527. http://dx.doi.org/10.7717/peerj.5527.
Texto completoBallard, F. J., M. Ross, F. M. Upton y G. L. Francis. "Specific binding of insulin-like growth factors 1 and 2 to the type 1 and type 2 receptors respectively". Biochemical Journal 249, n.º 3 (1 de febrero de 1988): 721–26. http://dx.doi.org/10.1042/bj2490721.
Texto completode Vasconcellos, Jaira F., Y. Terry Lee, Colleen Byrnes, Benjamin A. Clarke, Pauline C. Xu, Antoinette Rabel, Richard L. Proia y Jeffery L. Miller. "IGF2BP1 Protein Binding of Erythroblast Transcription Factor mRNA: A Cytoplasm-Localized Mechanism for Globin Gene Regulation". Blood 128, n.º 22 (2 de diciembre de 2016): 1009. http://dx.doi.org/10.1182/blood.v128.22.1009.1009.
Texto completoOuyang, Jun, Junqing Li, Dongwei Li, Jianlong Jiang, Tengfei Hao, Yujian Xia, Xiaofang Lu, Changhua Zhang y Yulong He. "IGF2BP2 Promotes Epithelial to Mesenchymal Transition and Metastasis through Stabilizing HMGA1 mRNA in Gastric Cancer". Cancers 14, n.º 21 (31 de octubre de 2022): 5381. http://dx.doi.org/10.3390/cancers14215381.
Texto completoChen, Hung-Ming, Chun-Chi Lin, Wei-Shone Chen, Jeng-Kai Jiang, Shung-Haur Yang, Shih-Ching Chang, Ching-Liang Ho et al. "Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 (IGF2BP1) Is a Prognostic Biomarker and Associated with Chemotherapy Responsiveness in Colorectal Cancer". International Journal of Molecular Sciences 22, n.º 13 (28 de junio de 2021): 6940. http://dx.doi.org/10.3390/ijms22136940.
Texto completoNeely, E. Kirk, Stephen D. Smith y Ron G. Rosenfeld. "Human leukemic T and B lymphoblasts produce insulin-like growth factor binding proteins 2 and 4". Acta Endocrinologica 124, n.º 6 (junio de 1991): 707–14. http://dx.doi.org/10.1530/acta.0.1240707.
Texto completoGlaß, Markus, Patrick Michl y Stefan Hüttelmaier. "RNA Binding Proteins as Drivers and Therapeutic Target Candidates in Pancreatic Ductal Adenocarcinoma". International Journal of Molecular Sciences 21, n.º 11 (11 de junio de 2020): 4190. http://dx.doi.org/10.3390/ijms21114190.
Texto completoSimon, Yvette, Sonja M. Kessler, Rainer M. Bohle, Johannes Haybaeck y Alexandra K. Kiemer. "The insulin-like growth factor 2 (IGF2) mRNA-binding protein p62/IGF2BP2-2 as a promoter of NAFLD and HCC?" Gut 63, n.º 5 (30 de octubre de 2013): 861–63. http://dx.doi.org/10.1136/gutjnl-2013-305736.
Texto completoSánchez-Sendra, Beatriz, Silvia Pérez-Debén, José F. González-Muñoz, Amelia Murgui y Carlos Monteagudo. "Prognostic Value of IGF2 mRNA-Binding Protein 3 (IGF2BP3) Intratumoral Expression in Melanoma Patients at the Time of Diagnosis: Comparative Analysis of RT-qPCR Versus Immunohistochemistry". Cancers 14, n.º 9 (7 de mayo de 2022): 2319. http://dx.doi.org/10.3390/cancers14092319.
Texto completoSingh, Vikash, Chethana P. Gowda, Vishal Singh, Ashwinkumar S. Ganapathy, Dipti M. Karamchandani, Melanie A. Eshelman, Gregory S. Yochum, Prashant Nighot y Vladimir S. Spiegelman. "The mRNA-binding protein IGF2BP1 maintains intestinal barrier function by up-regulating occludin expression". Journal of Biological Chemistry 295, n.º 25 (8 de mayo de 2020): 8602–12. http://dx.doi.org/10.1074/jbc.ac120.013646.
Texto completoRoss, M., G. L. Francis, L. Szabo, J. C. Wallace y F. J. Ballard. "Insulin-like growth factor (IGF)-binding proteins inhibit the biological activities of IGF-1 and IGF-2 but not des-(1-3)-IGF-1". Biochemical Journal 258, n.º 1 (15 de febrero de 1989): 267–72. http://dx.doi.org/10.1042/bj2580267.
Texto completoLund, Jacob, Mads T. Søndergaard, Cheryl A. Conover y Michael T. Overgaard. "Heparin-binding mechanism of the IGF2/IGF-binding protein 2 complex". Journal of Molecular Endocrinology 52, n.º 3 (6 de marzo de 2014): 345–55. http://dx.doi.org/10.1530/jme-13-0184.
Texto completoGlaß, Markus y Stefan Hüttelmaier. "IGF2BP1—An Oncofetal RNA-Binding Protein Fuels Tumor Virus Propagation". Viruses 15, n.º 7 (24 de junio de 2023): 1431. http://dx.doi.org/10.3390/v15071431.
Texto completoBraulke, T. "Type-2 IGF Receptor: A Multi-Ligand Binding Protein". Hormone and Metabolic Research 31, n.º 02/03 (enero de 1999): 242–46. http://dx.doi.org/10.1055/s-2007-978725.
Texto completoBallard, F. J., L. C. Read, G. L. Francis, C. J. Bagley y J. C. Wallace. "Binding properties and biological potencies of insulin-like growth factors in L6 myoblasts". Biochemical Journal 233, n.º 1 (1 de enero de 1986): 223–30. http://dx.doi.org/10.1042/bj2330223.
Texto completoForbes, B., F. J. Ballard y J. C. Wallace. "An insulin-like growth factor-binding protein purified from medium conditioned by a human lung fibroblast cell line (He[39]L) has a novel N-terminal sequence". Journal of Endocrinology 126, n.º 3 (septiembre de 1990): 497–506. http://dx.doi.org/10.1677/joe.0.1260497.
Texto completo